Skip to content

Impact of Glistenings in AcrySof Intraocular Lenses on Visual Quality

Impact of IOL Glistenings on Visual Quality and Function in Patients Implanted With a Single-Piece AcrySof IOL That Exhibits Glistening Formation

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01202981
Enrollment
200
Registered
2010-09-16
Start date
2010-07-31
Completion date
2013-06-30
Last updated
2014-12-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glistenings, Lenses, Intraocular, Visual Quality

Keywords

glistenings, contrast sensitivity, visual quality, straylight, AcrySof IOL

Brief summary

This study will assess the impact of IOL glistenings on visual quality and function in patients implanted with a single-piece AcrySof intraocular lens (IOL) that exhibits glistening formations. The primary objective is to determine if random light scattering (measured by C-Quant)correlates with severity of glistenings, other objective measures of visual function (visual acuity, low contrast visual acuity, low contrast visual acuity with glare), and subjective measures of patients' perceptions of their visual quality after cataract surgery (quality of life survey, reports of symptomology and satisfaction).

Interventions

None listed

Sponsors

University of Utah
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

1. Presence of obvious glistenings by slit lamp exam 2. Best spectacle corrected visual acuity of 20/20 or better on the Snellen chart at most recent exam

Exclusion criteria

1. Any central corneal pathology that could have impact on vision other than mild guttata felt unlikely to have any impact on corneal clarity. 2. Any documented glaucoma of any kind. 3. Any macular pathology except minimal drusen without retinal pigment epithelial pathology felt to be consistent with normal vision. 4. Any diabetic retinopathy other than minimal background diabetic retinopathy felt unlikely to affect vision. 5. Any other cause of central visual acuity loss including optic nerve, occipital cortex dysfunction or amblyopia. 6. Diagnosis of dry eye syndrome, defined as any corneal staining with fluorescein 7. Presence of any central posterior capsular opacification. Previous YAG laser capsulotomy is allowed. 8. Any surgical complication having to do with the capsule such as a broken capsule or zonular dialysis or iris trauma or any other complication felt to in any way impact upon the quality of the visual result. 9. Any contraindication to pupil dilation

Design outcomes

Primary

MeasureTime frameDescription
Light scatteringPost-opertativeCorrelation of random light scattering (measured with the C-Quant device) with severity of glistenings in the lenses

Secondary

MeasureTime frameDescription
Visual functionPost-operativeCorrelation of visual function (visual acuity, contrast acuity and constrast acuity with glare)with glistening severity
Visual qualityPost-operativeCorrelation of visual quality (measured with quality of life questionnaire, and subjective reports of symptoms) with glistening severity

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026